Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
American Well Corporation (NYSE: AMWL), commonly known as Amwell, is a U.S.-based digital healthcare and telehealth technology company that provides virtual care infrastructure, software platforms, and clinical integration tools for healthcare providers, insurers, and government organizations. The company operates primarily within the digital health, healthcare IT, and telemedicine industries, enabling remote medical consultations, hybrid care delivery, patient engagement, and clinical workflow management. Its core revenue drivers include subscription-based platform services, software licensing, implementation services, and virtual care enablement solutions for health systems and payers.
Amwell’s primary business revolves around its Amwell Converge platform, which integrates telehealth workflows, scheduling, clinical programs, and interoperability tools into healthcare delivery systems. The company serves large health systems, insurance providers, employers, and government healthcare agencies, with a particular focus on enterprise healthcare clients rather than direct-to-consumer telemedicine. Founded in 2006 by brothers Ido Schoenberg and Roy Schoenberg, the company evolved from an online physician consultation platform into an enterprise-grade virtual care infrastructure provider. Amwell expanded significantly during the COVID-19 pandemic as demand for remote healthcare delivery accelerated across hospitals and insurers.
Business Operations
Amwell generates revenue through enterprise software subscriptions, platform licensing, professional services, and virtual care technology deployments. Its operations are organized around virtual care enablement solutions for healthcare providers and payers, including telehealth infrastructure, digital care programs, behavioral health support, urgent care capabilities, and care coordination tools. The company’s flagship platform, Amwell Converge, supports video consultations, patient intake, digital workflows, electronic health record integration, and cloud-based clinical operations. Amwell has emphasized interoperability with major healthcare systems and electronic medical record providers.
The company operates primarily in the United States, though its technology capabilities support broader international use through partnerships and licensing relationships. Amwell has maintained strategic relationships with organizations such as Google Cloud, which became both a technology partner and investor through a strategic alliance announced in 2020. The company has also collaborated with major healthcare organizations and insurers to embed virtual care into existing healthcare delivery systems. Historically, Amwell acquired and integrated digital health assets, including SilverCloud Health and Conversa Health, to strengthen its behavioral health and automated patient engagement capabilities.
Strategic Position & Investments
Amwell’s strategic direction has centered on building an enterprise-focused virtual care ecosystem capable of supporting hybrid healthcare delivery models. The company has invested heavily in cloud-based infrastructure, artificial intelligence-enabled workflows, and integrated care coordination technologies designed to support long-term digital transformation in healthcare systems. Management has emphasized recurring platform revenue and deeper integration with hospital and payer systems as key growth priorities. Amwell has also focused on expanding behavioral health and asynchronous care capabilities through acquisitions and internal platform development.
Major strategic investments include the acquisitions of SilverCloud Health, a digital mental health platform, and Conversa Health, which specialized in automated virtual patient engagement and care pathways. These acquisitions were intended to broaden Amwell’s digital care offerings beyond video consultations into longitudinal patient management and behavioral healthcare. The company has also invested in scalable cloud infrastructure through its strategic partnership with Google Cloud, leveraging cloud computing and AI-related capabilities to modernize healthcare workflows and improve platform interoperability.
Geographic Footprint
Amwell is headquartered in Boston, Massachusetts, and primarily serves customers throughout the United States healthcare market. Its client base includes major health systems, insurers, employers, and government-related healthcare entities across numerous U.S. regions. The company’s operational influence is strongest in North America due to the structure of the U.S. healthcare reimbursement and provider ecosystem, which has been a central focus of its enterprise virtual care strategy.
Although Amwell’s commercial concentration remains largely domestic, the company has had international exposure through technology partnerships, multinational healthcare relationships, and previously acquired digital health assets with operations in regions such as Europe and the United Kingdom. Its cloud-based architecture and software platform are designed for scalability across global healthcare environments, though publicly available filings indicate that the majority of revenue has historically been generated within the United States.
Leadership & Governance
Amwell was co-founded by physicians and entrepreneurs Ido Schoenberg and Roy Schoenberg, who played major roles in shaping the company’s physician-centric virtual care strategy. Leadership has consistently emphasized healthcare system integration, enterprise partnerships, and long-term digital transformation in care delivery. The company’s governance structure includes executives with backgrounds in healthcare technology, digital health operations, enterprise software, and clinical services.
Key executives include:
- Ido Schoenberg – Chairman and Chief Executive Officer
- Roy Schoenberg – Co-Founder and former President and Co-Chief Executive Officer
- Robert Shepardson – Chief Financial Officer
- Phyllis Gotlib – Chief Commercial Officer
- Peter Antall, MD – Chief Medical Officer
- Murray Brozinsky – Chief Strategy Officer
Amwell’s leadership strategy has focused on positioning the company as a foundational infrastructure provider for hybrid healthcare delivery rather than solely a direct-to-consumer telemedicine brand. Public filings and investor communications, including SEC filings and earnings materials, consistently describe the company’s objective of enabling integrated digital healthcare experiences across providers, payers, and patients.